blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1919507

EP1919507 - NANOPARTICLES COMPRISING ANTIBACTERIAL LIGANDS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  12.07.2019
Database last updated on 12.07.2024
FormerExamination is in progress
Status updated on  06.10.2017
Most recent event   Tooltip12.07.2019Refusal of applicationpublished on 14.08.2019  [2019/33]
Applicant(s)For all designated states
MIDATECH LTD
4 & 5 Dunmore Court
Wootton Road
Abingdon
Oxford
Oxfordshire, OX136BH / GB
[2013/49]
Former [2008/20]For all designated states
Rademacher, Thomas William
4 & 5 Dunmore Court Wootton Road Abingdon, Oxford
Oxfordshire OX13 6BH / GB
For all designated states
Bradman, Godfrey
4 & 5 Dunmore Court Wootton Road Abingdon, Oxford
Oxfordshire OX13 6BH / GB
For all designated states
Penades Ullate, Soledad
Calle Serano E-113
28006 Madrid / ES
For all designated states
Ojeda Martinez de Castilla, Rafael
Calle Serano, E-113
28006 Madrid / ES
Inventor(s)01 / Radmacher, Thomas Wiliam
4& 5 Dunmore Court, Wootton Road
Abingdon, Oxford, Oxfordshire OX13 6BH / GB
02 / Bradman, Godfrey
4 & 5 Dunmore Court, Wootton Road
Abingdon, Oxford, Oxfordshire OX13 6BH / GB
03 / Penades Ullate, Soledad
c/o Consejo Superior De Investigaciones
Cientificas
Calle Serano E-113 28006 Madrid / ES
04 / Ojeda Martinez, DeCastilla
c/o Consejo Superior De Investigaciones
Cientificas
Calle Serano E-113 28006 Madrid / ES
 [2013/49]
Former [2008/20]01 / see applicant
...
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2008/20]Kiddle, Simon John, et al
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP / GB
Application number, filing date06765226.304.08.2006
[2008/20]
WO2006GB02923
Priority number, dateGB2005001607004.08.2005         Original published format: GB 0516070
US20050705175P04.08.2005         Original published format: US 705175 P
[2008/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007015105
Date:08.02.2007
Language:EN
[2007/06]
Type: A2 Application without search report 
No.:EP1919507
Date:14.05.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 08.02.2007 takes the place of the publication of the European patent application.
[2008/20]
Search report(s)International search report - published on:EP01.11.2007
ClassificationIPC:A61K47/48, A61K41/00, A61P31/04, A61P31/06
[2008/20]
CPC:
A61K47/552 (EP,US); A61K41/0052 (EP,US); A61K47/6923 (EP,US);
A61K47/6929 (EP,US); A61P31/04 (EP); A61P31/06 (EP);
B82Y5/00 (EP,US); Y02A50/30 (EP); Y10S977/773 (EP,US);
Y10S977/906 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/20]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:NANOTEILCHEN MIT ANTIBAKTERIELLEN LIGANDEN[2008/20]
English:NANOPARTICLES COMPRISING ANTIBACTERIAL LIGANDS[2008/20]
French:NANOPARTICULES COMPRENANT DES LIGANDS ANTIBACTERIENS[2008/20]
Entry into regional phase22.02.2008National basic fee paid 
22.02.2008Designation fee(s) paid 
22.02.2008Examination fee paid 
Examination procedure15.02.2008Amendment by applicant (claims and/or description)
22.02.2008Examination requested  [2008/20]
07.11.2013Despatch of a communication from the examining division (Time limit: M06)
24.03.2014Reply to a communication from the examining division
27.09.2017Despatch of a communication from the examining division (Time limit: M06)
09.04.2018Reply to a communication from the examining division
24.01.2019Cancellation of oral proceeding that was planned for 14.02.2019
14.02.2019Date of oral proceedings (cancelled)
21.03.2019Despatch of communication that the application is refused, reason: substantive examination [2019/33]
31.03.2019Application refused, date of legal effect [2019/33]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.11.2013
Fees paidRenewal fee
21.08.2008Renewal fee patent year 03
05.01.2010Renewal fee patent year 04
20.08.2010Renewal fee patent year 05
22.08.2011Renewal fee patent year 06
23.08.2012Renewal fee patent year 07
30.08.2013Renewal fee patent year 08
29.08.2014Renewal fee patent year 09
24.08.2015Renewal fee patent year 10
24.08.2016Renewal fee patent year 11
25.08.2017Renewal fee patent year 12
10.08.2018Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
31.08.200904   M06   Fee paid on   05.01.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]WO0232404  (CONSEJO SUPERIOR INVESTIGACION [ES], et al) [DX] 1,4-7,9,10,14-32,34 * page 8, line 30 - page 9, line 5 * * page 12, line 25 - page 13, line 14 * * page 17, lines 11-16 * * claims 1-24,26,27,33-35 * * figures 1,2 *;
 [X]WO03022999  (GENOMIC PROFILING SYSTEMS INC [US]) [X] 1-4,9,15,18-22,24,30 * page 24, lines 13-21 * * page 71, lines 11-14 *;
 [X]WO2004102196  (CHENGDU KUACHANG MEDICAL IND L [CN], et al) [X] 1-4,6,7,9,18-22,24,30 * abstract *;
 [DXA]WO2004108165  (CONSEJO SUPERIOR INVESTIGACION [ES], et al) [DX] 1,2,4-7,9-34,36 * page 19, lines 5-13 * * page 24, lines 26-34 * * page 29, lines 28-32 * * page 46, line 33 * * examples 1-3 * * claims 1-25,27-32,52-57 * [A] 37-39;
 [X]WO2005044365  (TRITON BIOSYSTEMS INC [US], et al) [X] 1,2,4,6,8,9,15,16,18-25,30-36,38,39 * page 4, line 29 - page 5, line 5 * * page 6, lines 8-12 * * page 8, lines 26-28 * * page 10, lines 19-26 * * page 14, lines 1-3,12,13 * * page 16, line 27 - page 17, line 5 * * page 19, line 26 - page 20, line 12 * * page 39, lines 16-18 *;
 [PX]EP1624306  (CHENGDU KUACHANG MEDICAL IND L [CN], et al) [PX] 1-4,6,7,9,18-22,24,30 * claims 65,66 * * paragraph [0017] *;
 [PA]WO2006037979  (MIDATECH LTD [GB], et al) [PA] 1,2,4-36 * figure 8/11 ** claim - *;
 [E]WO2006108405  (MAGFORCE NANOTECHNOLOGIES AG [DE], et al) [E] 1-4,6,7,9,15-22,24,25,30-34,36,38,39 * page 3, line 25 - page 4, line 10 * * page 5, lines 4-6 * * page 8, line 6 - line 20 * * page 17, lines 15,16 * * page 18, lines 20-22 * * example 1 * * claims 1,7-14 *;
 [X]  - LIN YA-SHIUAN ET AL, "Affinity capture using vancomycin-bound magnetic nanoparticles for the MALDI-MS analysis of bacteria.", ANALYTICAL CHEMISTRY 15 MAR 2005, (20050315), vol. 77, no. 6, ISSN 0003-2700, pages 1753 - 1760, XP002446940 [X] 1-4,6,8,9,15,18-22,24,30 * page 1753, column 2, paragraph 2 - page 1754, column 1, paragraph 2 * * scheme 1 * * page 1754, column 2 *

DOI:   http://dx.doi.org/10.1021/ac048990k
 [X]  - GU HONGWEI ET AL, "Using biofunctional magnetic nanoparticles to capture gram-negative bacteria at an ultra-low concentration.", CHEMICAL COMMUNICATIONS (CAMBRIDGE, ENGLAND) 7 AUG 2003, (20030807), no. 15, ISSN 1359-7345, pages 1966 - 1967, XP002446941 [X] 1-4,6,9,11-13,15,16,18-22,24,30 * abstract * * scheme 1 * * page 1966, column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1039/b305421g
 [A]  - SUN S ET AL, "Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices", SCIENCE 17 MAR 2000 UNITED STATES, (20000317), vol. 287, no. 5460, ISSN 0036-8075, pages 1989 - 1992, XP002446942 [A] 11-13 * page 1989, column 2, paragraph LAST - column 3, paragraph 1 *

DOI:   http://dx.doi.org/10.1126/science.287.5460.1989
 [X]  - GU, HONGWEI ET AL, "Presenting vancomycin on nanoparticles to enhance antimicrobial activities", NANO LETTERS , 3(9), 1261-1263 CODEN: NALEFD; ISSN: 1530-6984, (2003), XP002446943 [X] 1,3,4,6,9,14-16,18,21,22,24,30 * page 1261, column 2, paragraph 2 * * scheme 1 *

DOI:   http://dx.doi.org/10.1021/nl034396z
 [X]  - TOM RENJIS T ET AL, "Ciprofloxacin-protected gold nanoparticles.", LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2 MAR 2004, (20040302), vol. 20, no. 5, ISSN 0743-7463, pages 1909 - 1914, XP002446944 [X] 1,3,4,6,9,14,18,19,21,22,24,25,31,32,34 * abstract * * page 1909, column 2, paragraph 2 - page 1910, column 1, paragraph 1 * * page 1910, column 1, paragraph LAST - column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1021/la0358567
 [X]  - RAMAKRISHNAN R ET AL, "SENSITIVE ASSAY FOR IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS, BASED ON DIRECT DETECTION OF GENOMIC DNA BY USE OF GOLD NANOPARTICLE PROBES", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, US, (200410), vol. 50, no. 10, ISSN 0009-9147, pages 1949 - 1952, XP001207433 [X] 1,4,9,10,14-18,22,24,30 * figure 1 *

DOI:   http://dx.doi.org/10.1373/clinchem.2004.036723
 [A]  - STORHOFF J J ET AL, "One-pot colorimetric differentiation of polynucleotides with single base imperfection using gold nanoparticle probes", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (19980311), vol. 120, ISSN 0002-7863, pages 1959 - 1964, XP002113277 [A] 15-17 * page 1960, column 1, paragraph 4 - column 2, paragraph 3 *

DOI:   http://dx.doi.org/10.1021/ja972332i
 [X]  - JENSEN KATIE L ET AL, "Use of gold nanoparticles to identify targets of membrane-active steroid antiobiotics", ABSTRACTS OF PAPERS AMERICAN CHEMICAL SOCIETY, & 223RD NATIONAL MEETING OF THE AMERICAN CHEMICAL SOCIETY; ORLANDO, FL, USA; APRIL 07-11, 2002, (2002), vol. 223, no. 1-2, ISSN 0065-7727, page CHED 855, XP002446945 [X] 1,4,9,14,18,22,24 * abstract *
 [X]  - LIN C-C ET AL, "Selective binding of mannose-encapsulated gold nanoparticles to type 1 pili in Escherichia coli", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 10 APR 2002 UNITED STATES, (20020410), vol. 124, no. 14, ISSN 0002-7863, pages 3508 - 3509, XP002446946 [X] 1,4,6,9,14-18,21-24,26-30 * scheme 1 * * page 3508, column 2 *

DOI:   http://dx.doi.org/10.1021/ja0200903
    [ ] - LIN C-C ET AL, "Detailed experimental procedures, stability measurements, competition assays and data analyses for UV-vis, TEM, XPS, IR and NMR spectroscopy", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, SUPPLEMENTAL MATERIALS, United State, (20020410), vol. 124, no. 14, pages 1 - 7, XP002448131 [ ] * page 3: synthesis of m-AuNP,1 *

DOI:   http://dx.doi.org/10.1021/ja015113c
 [DX]  - JESUS M DE LA FUENTE ET AL, "Understanding carbohydrate-carbohydrate Interactions by means of glyconanotechnology", GLYCOCONJUGATE JOURNAL, KLUWER ACADEMIC PUBLISHERS, BO, (20040101), vol. 21, no. 3-4, ISSN 1573-4986, pages 149 - 163, XP019207009 [DX] 1,4-7,9,14-16,18,19,21-24,26,27,29,30 * page 155, section "Gold glycanoparticles" * * figures 8,13 * * page 161, column 1 *

DOI:   http://dx.doi.org/10.1023/B:GLYC.0000044846.80014.cb
 [XA]  - ZHAROV VLADIMIR P ET AL, "Photothermal guidance for selective photothermolysis with nanoparticles", PROC SPIE INT SOC OPT ENG; PROCEEDINGS OF SPIE - THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING; PROGRESS IN BIOMEDICAL OPTICS AND IMAGING - LASER INTERACTION WITH TISSUE AND CELLS 2004, (2004), vol. 5319, pages 291 - 300, XP002446947 [X] 1,4,9,14,15,18,21,22,24,25,31,32,34,35 * abstract * * pages 297-298, section 4 * [A] 37

DOI:   http://dx.doi.org/10.1117/12.532011
 [A]  - NARUSE YUJIRO, "Theoretical concept of physical antibiotics using nanoparticles", JPN J APPL PHYS PART 1 REGUL PAP SHORT NOTE REV PAP; JAPANESE JOURNAL OF APPLIED PHYSICS, PART 1: REGULAR PAPERS AND SHORT NOTES AND REVIEW PAPERS MAY 2005, (200505), vol. 44, no. 5 A, pages 3330 - 3332, XP002446948 [A] 1,24,25,31-39 * abstract *

DOI:   http://dx.doi.org/10.1143/JJAP.44.3330
 [PX]  - NIRMALA GRACE A ET AL, "Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles-A brief study", COLLOIDS AND SURFACES A: PHYSICOCHEMICAL AND ENGINEERING ASPECTS 05 APR 2007 NETHERLANDS, (20070405), vol. 297, no. 1-3, ISSN 0927-7757, pages 63 - 70, XP002446949 [PX] 1,3,4,9,14,18,21,22,24,25,31,32,34,35 * available online 13 October 2006 * * abstract * * page 64, column 2, section 2.3 * * page 70, column 1, paragraph LAST *

DOI:   http://dx.doi.org/10.1016/j.colsurfa.2006.10.024
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.